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Abstract Diacylglycerol kinases (DGKs) regulate the key
signaling intermediates diacylglycerol (DAG) and phosphatidic
acid (PA). We isolated cDNA clones of mouse diacylglycerol
kinase j (mDGKj) and found that it shares 88% identity at the
nucleic acid level and 95.5% identity at the amino acid level with
human DGKj (hDGKj). Murine DGKj protein rose gradually
during embryonic development, and was abundant in newborn
and adult brains. By RNA whole-mount in situ hybridization,
mDGKj was shown to be expressed in spinal ganglia and limb
buds at low level in E11.5 embryos and at higher level in E12.5
embryos. In E13.5 embryos, DGKj mRNA was highly expressed
in vibrissa follicles, in spinal ganglia, and in the interdigital
regions of the developing limbs. Northern blotting showed that
DGKj expression was limited to specific anatomical regions of
the brain. Thus, the expression of DGKj is regulated temporally
and spatially during mammalian development and correlates with
the development of sensory neurons and regions undergoing
apoptosis.
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1. Introduction
Diacylglycerol (DAG) is a key intermediate in the synthesis
of complex lipids and serves as an important second messen-
ger. DAG exerts its signaling function by activating protein
kinase C (PKC), which in turn regulates many cellular re-
sponses including growth, di¡erentiation and apoptosis [1].
In addition, the level of DAG is essential for cellular events
such as protein export from the Golgi complex in yeast [2].
The signals from DAG are terminated by its conversion to
phosphatidic acid (PA), a reaction that is catalyzed by dia-
cylglycerol kinase(s) (DGK). The role of DGK in regulating
DAG levels was established by the observation that overex-
pression of DGKK decreased the elevated DAG level in ras-
transformed ¢broblasts [3]. In ending the signal(s) from DAG,
the DGK reaction generates PA as the product which has
been implicated in the regulation of DNA synthesis, in the
induction of c-myc, c-fos, platelet-derived growth factor, in
cAMP formation [4^6], and in modulating the activity of n-
chimaerin [7] and NF1 [8]. Therefore, the DGK reaction oc-
cupies an interesting niche ^ it removes one lipid messenger
but creates another. Besides its e¡ect on DAG signaling, the
DGK reaction is the ¢rst step in the recycling of phospha-
tidylinositol species following their hydrolysis. Disruption of
this pathway can have severe consequences as demonstrated
by the Drosophila rdgA (DGK2) mutant in which photorecep-
tor cells degenerate within a week after eclosion [9].
The known eight mammalian DGKs can be divided into
¢ve structural subgroups and di¡er in their expression pat-
terns, activators, and substrate speci¢city. Type I includes
DGKK [10,11], L [12], Q [13] and is de¢ned by the presence
of E-F hand motifs at the N-termini, which bind Ca2 with
di¡erent a⁄nities [14]. DGKK was originally found in lym-
phocytes and oligodendrocytes, while DGKL was cloned from
brain and was found to be expressed in the olfactory tu-
bercles, nucleus accumbens, caudate and putamen [12].
DGKQ, cloned from a HepG2 library, was found to be en-
riched in retina [13]. DGKN [15] and DGKR [16] are type II
DGKs, which have a pleckstrin domain (PH domain) at their
N-termini. The PH domain has been found in a number of
proteins involved in signal transduction and can serve as a site
of protein-protein and protein-phospholipid interactions [17^
19]. DGKN was cloned from testis and HepG2 cells, and is
primarily expressed in skeletal muscle and testis [15]. The ex-
pression of DGKR is found in a broad range of tissues and is
regulated by glucocorticoids [16]. The third type of DGK,
DGKO [20], has the simplest structure and shows substrate
speci¢city for DAG with an arachidonoyl residue at the sn-2
position. DGKO mRNA has been found in retina, brain, tes-
tis, heart, spleen and lung [21]. Type IV is typi¢ed by DGKj
[22] which has two zinc ¢ngers, four ankyrin repeats at its C-
terminus and a unique region homologous to MARCKS
phosphorylation site domain. DGKj is highly expressed in
the brain and skeletal muscle. RNA in situ hybridization by
using rat brain section showed that DGKj is expressed in
cerebral cortex, hippocampus and olfactory bulb [23]. The
Drosophila DGK2, rdgA gene also belongs to this type IV
group and is expressed almost exclusively in the retina [9].
Proteins containing ankyrin repeats are involved in a variety
of cellular processes such as gene regulation [24^26] and cell
cycle control [27]. The type V DGK, DGKa, is mostly ex-
pressed in brain and small intestine. It contains three cys-
teine-rich repeats ^ rather than two ^ and a ras-binding do-
main [28].
Here, we report the cloning and characterization of murine
DGKj. We also studied the developmental expression of
mDGKj, and detected the protein as early as on day 10.5
of embryogenesis with a marked change at later stages of
development. The spatial distribution of the mDGKj message
was determined by RNA whole-mount in situ hybridization
in mouse embryos at various stages of development. We
found that DGKj expression is temporally and spatially re-
stricted, and is highly expressed in tissues involved in sensory
function.
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2. Materials and methods
2.1. Isolation and characterization of murine cDNAs
Hybridizations were performed in 5USSPE, 5UDenhardt’s, 0.2%
SDS, and 0.1% Na2P4O7 at 52.5‡C for low stringency and 65‡C for
normal stringency. Primers for genomic PCR screening are: LD121-2,
5P CAG CAT CTT AGC TAC ACA GTG CTG 3P and LD121-3, 5P
ATC ACC AAG TCG GGC CTC CAG 3P.
2.2. Western immunoblots for murine DGKj protein expression
Mouse embryos of di¡erent ages, newborn mouse brain and adult
mouse brain were homogenized in 50 mM Tris-HCl pH 8.0, 2 Wg/ml
pepstatin A, 20 Wg/ml leupeptin, 40 Wg/ml TLCK, 20 Wg/ml aprotinin,
20 WM BH4, 3 mM DTT, 10 mM CHAPS and 1 mM PMSF. All
homogenates were frozen and stored at 370‡C until assayed. Samples
with V100 Wg protein were loaded on a 7.5% SDS-PAGE gel and
Western blotting was performed as previously described [22]. The
protein concentration of each sample was determined by standard
BCA protein assay. The L-actin antibody was used as a control to
ensure that an equal amount of protein was loaded in each lane. The
Western blotting protocol with ECL detection is capable of detecting
as little as 1 pg protein (Amersham). For the peptide competition
experiment, the primary antibody was incubated with 4 volumes of
peptide (0.1 mg/ml) at 4‡C for 2 h prior to incubation with the mem-
brane.
2.3. RNA whole-mount in situ hybridization
The RNA whole-mount in situ hybridization was performed as
previously described [29]. The mouse strain used was Swiss Webster.
The day that a copulation plug was observed was considered embry-
onic day 0.5 (E0.5). Embryos were collected from timed pregnant
females. Embryos were dissected free of extraembryonic membranes
in phosphate-bu¡ered saline (PBS).
Two mDGKj antisense RNA probes were used. The ¢rst probe was
a 716-bp 3P PstI/EcoRI fragment. It was subcloned into pBluescript II
and used to make digoxigenin-labeled RNA probe by in vitro tran-
scription (Boehringer Mannheim). The second one was from the cat-
alytic domain region of the mDGKj gene. A pair of primers with T7
or T3 promoters attached was used to amplify a 558-bp mDGKj
cDNA fragment. Ampli¢ed PCR products were used as templates
to make digoxigenin-labeled RNA probes by using an in vitro tran-
scription kit (Boehringer Mannheim). The sequences of the primers
were:
The probe concentration was 0.5 Wg/ml.
2.4. Northern blotting
Human brain Northern blots I and II were purchased from Clon-
tech. Two ¢lters with 2 Wg mRNA from di¡erent regions of the hu-
man brain were probed with a digoxigenin-labeled 761-bp fragment
of hDGKj as described previously [22]. The L-actin cDNA probe
was used to ensure that an equal amount of mRNA was loaded in
each lane. The detection limit for digoxigenin-labeled riboprobe is
around 0.1 pg according to manufacturer estimation (Boehringer
Mannheim).
3. Results
3.1. Isolation and characterization of murine cDNA and
genomic clones
We screened a mouse brain cDNA library with a SmaI-
HindIII probe derived from the hDGKj cDNA by low strin-
gency hybridization. The ¢rst identi¢ed clone (3-2) di¡ered
from any known mouse DGKs and showed a high percentage
of sequence identity with hDGKj, suggesting it was the mur-
ine homolog of hDGKj. The translation initiation site was
not found either in this clone or others (7-1 and 8-1) isolated
from another two rounds of screening. A 500-bp mouse ge-
nomic fragment was ampli¢ed by polymerase chain reaction
(PCR) and used to isolate four P1 genomic clones. Splicing
patterns were conserved between hDGKj [30] and mDGKj as
demonstrated by reverse transcriptase-PCR. As summarized
in Fig. 1A, the composite mDGKj sequence was obtained
from mouse cDNA clone 3-2, 7-1, 8-1 and the mouse P1
genomic clones. The initiation ATG of the open reading
frame was identi¢ed as the ¢rst ATG sequence following
with an in-frame stop codon 9-bp upstream. The ¢rst zinc
¢nger of the mDGKj protein includes the sequence
HX11CX6CX12CX2CX4HX2CX10C and the second includes
HX11CX2CX19CX2CX4HX4CX9C. The cysteine and histidine
residues of the two zinc ¢ngers are completely conserved be-
tween hDGKj and mDGKj proteins. The MARCKS phos-
phorylation site is conserved between hDGKj and mDGKj
proteins except for a (m)Arg270 to (h)Lys269 replacement in
the mDGKj protein. In addition, the catalytic domain of the
mDGKj protein is similar to all known DGKs. The main
feature that distinguishes DGKj is the ankyrin repeats, and
the deduced mDGKj protein, like the human protein, has
four such repeats (Fig. 1B). Mouse DGKj shares 88% and
95.5% identity with the human sequence at the nucleotide and
amino acid level, respectively.
3.2. Immunodetection of the murine DGKj protein: the
DGKj protein accumulates during late embryogenesis
and post-natal development
Human DGKj and murine DGKj proteins have an iden-
tical peptide sequences at their C-termini, thus, we were able
to use a previously described antibody [22]. This antibody
recognized a V120-kDa protein in homogenates of the mouse
brain, and pre-incubation with the peptide antigen block the
recognition indicating speci¢c binding (Fig. 2A). We next ex-
amined the expression of mDGKj during embryonic develop-
ment by performing Western immunoblots of homogenates
from whole embryos and from brains of newborn and adult
mice. The mDGKj protein was detected in the homogenates
of E10.5 embryos, and the protein level increased gradually
during development (Fig. 2B). A band (indicated by an ar-
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Fig. 1. Sequence of the murine DGKj cDNA. A: The overlapping
map of representative clones. The cDNA and genomic clones were
isolated as described (Section 3). The clones were sequenced in an
automated ABI system. B: The nucleic acid sequence and deduced
amino acid sequence of mDGKj. The zinc ¢ngers are underlined,
and conserved cysteine and histidine residues are marked with *.
Serine residues within the MARCKS homology region are marked
by +. The residues within the ATP binding motif are double under-
lined. The ankyrin motifs are displayed within boxes.
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Fig. 1 (continued).
L. Ding et al./FEBS Letters 429 (1998) 109^114 111
row), V5^10 kDa smaller than the full-length protein, was
detected in embryo homogenates and its recognition was also
blocked by pre-incubation with the peptide antigen. We spec-
ulate that it is a proteolytic product since its intensity was
variable and a PEST sequence was found in the N-terminus
of DGKj [22]. In ¢ve independent experiments, we found a
high level of DGKj protein in the brain of newborn mice, and
a further two-fold increase at the DGKj protein level in adult
mouse brain. The DGKj signal was normalized to L-actin
(Fig. 2B).
3.3. Patterns of DGKj expression: examination of DGKj
by RNA whole-mount in situ hybridization indicates
that DGKj is expressed predominantly in sensory
structures
After ¢nding the change in DGKj expression during devel-
opment, we examined its tissue distribution by in situ hybrid-
ization for mRNA on whole-mount preparations of mouse
embryos. Antisense and sense probes to mDGKj were synthe-
FEBS 20256 8-6-98 ^ Pagina 112 Cyaan Magenta Geel Zwart
Fig. 2. The mDGKj protein level changes during mouse embryo-
genesis. A: 100 Wg of protein of mouse brain homogenate was
loaded in each lane and probed with the a⁄nity puri¢ed anti-
DGKj antibody at a concentration of 1 Wg/ml. In the control ex-
periment, pre-incubation with the immunogen-peptide (4 volumes
0.1 mg/ml peptide+1 volume 1 mg/ml antibody) signi¢cantly blocked
the recognition of the DGKj protein. B: Embryos at di¡erent
stages were dissected and homogenized. 100 Wg of protein from em-
bryo homogenates, newborn brain and adult brain homogenates
was loaded in each lane. They were probed with the a⁄nity puri¢ed
anti-DGKj antibody. The L-actin antibody was used as a control to
show that an equal amount of protein was loaded in each lane.
This is a representative result from ¢ve independent experiments.
6
Fig. 3. Murine DGKj is highly expressed in the sensory nerve system during mouse embryogenesis. Mouse embryos at di¡erent stages were hy-
bridized with DGKj antisense and sense digoxigenin-labeled probes as described in Section 2.3 (blue-purple staining represents the positive sig-
nals). The DGKj sense probe gave no speci¢c staining. A: Low level expression of DGKj in somites, limb buds and spinal ganglia in E11.5
day embryos. B: Strong expression of DGKj in spinal ganglia, limb buds and low level expression in the follicles of vibrissae in E12.5 day em-
bryos. C: Constitutively high level expression in limbs and spinal ganglia, and the follicles of vibrissa in E13.5 day embryos. D: Expression of
DGKj in umbilical vessels and nipple primordia.
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sized and used to examine the expression of DGKj in E10.5,
E11.5, E12.5, and E13.5 embryos. In E10.5 embryos, we could
not de¢ne a tissue-speci¢c pattern of expression because the
signals were not su⁄ciently above the background. In E11.5
embryos, we observed low level expression in somites, spinal
ganglia, and limb buds (Fig. 3A). We detected much stronger
expression of DGKj in spinal ganglia and limb buds in E12.5
embryos (Fig. 3B). Additionally, very strong expression was
found in the interdigital regions of the limb where cells are
undergoing apoptosis to create the fully developed digits.
DGKj staining was very strong in spinal ganglia and high-
lighted the segmentation of the embryo. Interestingly, the spi-
nal cord was not highly labeled (Fig. 3B). The dorsal root
ganglia are comprised of the cell bodies of sensory neurons
and our results demonstrate that DGKj is highly expressed in
them. When we examined E13.5 day embryos, we found that
DGKj was highly expressed in the follicles of the vibrissae, in
spinal ganglia, and in limb buds (Fig. 3C). The vibrissa follicle
contains venous sinuses and sensory nerve ¢bers within a
connective tissue sheath and is ¢rst observable during the
13th embryonic day. The strong DGKj staining in the fol-
licles of the vibrissae of E13.5 embryos suggests that DGKj is
expressed from the initiation of vibrissae. We also observed
staining in the umbilical vessels of E13.5 embryos (Fig. 3D),
which is noteworthy since hDGKj was originally cloned from
an umbilical vein endothelial cell library [22]. Interestingly,
expression of DGKj also was detected in the nipple primordia
of E13.5 embryos (Fig. 3D). We observed DGKj staining in
the brain of the embryos, but the precise anatomical local-
ization of the signal was not easily revealed by this technique.
Both probes mentioned in Section 2.3 gave us identical stain-
ing patterns. In all cases hybridization with the sense probe
was performed to con¢rm that the pattern observed with the
antisense probe was speci¢c.
3.4. Northern blotting of isolated regions of brain de¢nes
speci¢c patterns of expression
To re¢ne the localization of DGKj expression in the brain,
we used Northern blotting to examine mRNA samples from
speci¢c regions of human brain. The membranes were hybrid-
ized with a 761-bp digoxigenin-labeled hDGKj probe. The
hybridization was performed as previously described [22]. We
detected a band at 3.7-kb position in the whole brain sample,
as expected. Interestingly, the expression level varied among
the di¡erent regions with strong expression in cerebellum,
cerebral cortex, and hippocampus. In contrast, the expression
of DGKj in the spinal cord, medulla of the brain, and thal-
amus was low (Fig. 4). A L-actin probe was used as a control
to con¢rm the same amount of the mRNA loaded and the
integrity of the mRNA in each lane demonstrating the same
amount of mRNA from di¡erent regions of brain was loaded.
These results are consistent with the in situ hybridization ex-
periment in which we did not detect signi¢cant staining in the
spinal cord of embryos of di¡erent ages. Thus, DGKj expres-
sion is limited to speci¢c regions of the human brain.
4. Discussion
To study the developmental regulation and functions of
DGKj, we cloned the mDGKj and analyzed the expression
of this gene during mouse embryogenesis. Murine DGKj has
highest sequence similarity with hDGKj (97%) and Drosophi-
la DGK2, rdgA (49%) at the amino acid level. The deduced
mDGKj protein has the domain motifs that de¢ne the type
IV DGKs: two cysteine-rich repeats, a conserved catalytic
domain, and four ankyrin repeats at the C-terminus. Like
the other members of the DGK family, mDGKj shares the
greatest homology with other DGKs in the catalytic domain.
Within that domain DGKj has the conserved putative ATP
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Fig. 4. Analysis of DGKj mRNA from di¡erent regions of the human brain. Two ¢lters with 2 Wg mRNA from di¡erent brain regions were
probed with a fragment of the hDGKj. A sample from whole brain shows a band at 3.7 kb. The expression level of DGKj varies among dif-
ferent regions of brain, high in cerebral cortex, cerebellum, hippocampus, occipital pole, frontal lobe, temporal lobe, putamen, amygdala and
caudate nucleus, and low in spinal cord, medulla, corpus callosum, substantia nigra, subthalamic nucleus and thalamus.
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binding site GXGXXG, of which a mutation in the second
glycine in Drosophila DGK2 causes the retinal degeneration
phenotype [9].
We studied mDGKj expression in embryos from E10.5 to
E14.5 and found that the expression increases gradually dur-
ing embryogenesis. We observed that brains of both newborn
and adult mice have abundant DGKj protein suggesting that
DGKj may be involved in neuronal development and func-
tion. We determined the location of the DGKj mRNA in
developing embryos and found that it is highly expressed in
the sensory nerve system including the dorsal root ganglia and
vibrissa follicles. The expression pattern of DGKj shows sim-
ilarity to the expression pattern of the patched regulatory gene
at some stages [31]. Patched is a part of the hedgehog signal-
ing pathway, which is down-regulated by protein kinase A.
There is no known relationship between this pathway and the
DGK-mediated signaling, but our ¢ndings show they have
overlapping expression during development. This suggests a
potential interaction between them but more experimental
evidence is needed to distinguish whether this indicates func-
tional relationship. Our whole-mount in situ hybridization
method was not su⁄ciently sensitive to de¢ne subregions of
the mouse embryonic brain, so we used samples from di¡erent
anatomical regions of the human brain to test whether the
DGKj mRNA is limited to speci¢c regions of the brain.
DGKj is highly expressed in the sensory nervous system,
while expression is low in other areas, particularly the spinal
cord.
Our data demonstrate that the expression of DGKj is sub-
ject to strict temporal and spatial regulation during mamma-
lian development. Its tissue-speci¢c expression pattern is char-
acterized by selective expression in many sensory components
of the nerve system. At the same time, the expression of
DGKj overlaps signi¢cantly with the pattern observed with
other DGK isoforms [12,21,28]. Although DGK isoforms dif-
fer in substrate speci¢city and cofactor usage, when two or
more DGK isoforms are expressed in the same cells, they may
have complementary functions, or act in concert to regulate
the level of DAG and/or other important lipid messengers.
They may also be functionally redundant in these cells, mean-
ing one can compensate for the functional loss of the other.
On the other hand, DGKj may have unique and indispensa-
ble functions especially where it is expressed alone or at a
much higher level than other DGK isoforms. Taken together,
it is likely that di¡erent DGK isoforms have unique functions,
but also may act cooperatively to control cellular events such
as growth and di¡erentiation.
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